Literature DB >> 8548390

Leflunomide: an active antiinflammatory and antiproliferative agent in models of dermatologic disease.

E S Kurtz1, S C Bailey, F Arshad, A A Lee, P A Przekop.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8548390     DOI: 10.1007/bf01778324

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  6 in total

1.  Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake.

Authors:  J P Magaud; I Sargent; D Y Mason
Journal:  J Immunol Methods       Date:  1988-01-21       Impact factor: 2.303

Review 2.  Effects of leflunomide on immune responses and models of inflammation.

Authors:  R R Bartlett; H Anagnostopulos; T Zielinski; T Mattar; R Schleyerbach
Journal:  Springer Semin Immunopathol       Date:  1993

3.  Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis.

Authors:  G K Reid; S Kargman; P J Vickers; J A Mancini; C Léveillé; D Ethier; D K Miller; J W Gillard; R A Dixon; J F Evans
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

4.  Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide.

Authors:  T Mattar; K Kochhar; R Bartlett; E G Bremer; A Finnegan
Journal:  FEBS Lett       Date:  1993-11-15       Impact factor: 4.124

5.  Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker.

Authors:  P P Bradley; D A Priebat; R D Christensen; G Rothstein
Journal:  J Invest Dermatol       Date:  1982-03       Impact factor: 8.551

6.  Tachyphylaxis in 12-0-tetradecanoylphorbol acetate- and arachidonic acid-induced ear edema.

Authors:  J M Young; B M Wagner; D A Spires
Journal:  J Invest Dermatol       Date:  1983-01       Impact factor: 8.551

  6 in total
  1 in total

1.  Cyclooxygenase-2 and its regulation in inflammation.

Authors:  Y S Bakhle; R M Botting
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.